Alpha Lipoic Acid (ALA) vs DIM (Diindolylmethane)

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

Alpha Lipoic Acid (ALA)DIM (Diindolylmethane)
CategorySupplementsSupplements
Standard Dose300-600mg R-ALA daily100-200mg DIM daily
TimingOn empty stomach, 30-60 min before meals. Split doses for higher amounts.With meals (fat enhances absorption). Consistent daily dosing for estrogen metabolism modulation.
Cycle Durationongoing or cycle 12 weeks on, 4 weeks offongoing or cycle 8-12 weeks on, 4 weeks off
Evidence Levelstrong_humanmoderate_human

Mechanism

ALA is a dithiol compound that functions as a cofactor for mitochondrial alpha-keto acid dehydrogenases (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase). Both ALA and its reduced form DHLA are potent antioxidants capable of regenerating other antioxidants including vitamin C, vitamin E, and glutathione. ALA activates AMPK, improving glucose uptake via GLUT4 translocation, and modulates NF-kB-mediated inflammatory signaling. It chelates redox-active metals (Fe2+, Cu2+).

Standard Dosing

300-600mg R-ALA daily

Timing

On empty stomach, 30-60 min before meals. Split doses for higher amounts.

Cycle Duration

ongoing or cycle 12 weeks on, 4 weeks off

Side Effects

  • GI upset/nausea
  • Skin rash
  • Hypoglycemia symptoms
  • Body odor changes

Contraindications

  • Thiamine (B1) deficiency (ALA increases thiamine demand)
  • Hypoglycemia-prone individuals without monitoring
  • Autoimmune thyroid conditions (monitor thyroid function)

Best Stacking Partners

NACCoQ10Acetyl-L-CarnitineBiotinChromium

Mechanism

DIM is formed from indole-3-carbinol (I3C, from cruciferous vegetables) via acid condensation in the stomach. It modulates estrogen metabolism by promoting the 2-hydroxylation pathway (producing 2-hydroxyestrone, considered 'protective' estrogen) over the 16alpha-hydroxylation pathway (producing 16alpha-hydroxyestrone, considered proliferative) and the 4-hydroxylation pathway (producing 4-hydroxyestrone, genotoxic). DIM binds the aryl hydrocarbon receptor (AhR), inducing Phase I (CYP1A1, CYP1A2) and Phase II enzymes that facilitate estrogen detoxification. It also inhibits aromatase and has anti-androgen receptor effects (competitive binding).

Standard Dosing

100-200mg DIM daily

Timing

With meals (fat enhances absorption). Consistent daily dosing for estrogen metabolism modulation.

Cycle Duration

ongoing or cycle 8-12 weeks on, 4 weeks off

Side Effects

  • Harmless dark-colored urine
  • GI upset
  • Headache
  • Changes in menstrual cycle
  • Potential anti-androgenic effects at high doses in men

Contraindications

  • Estrogen-dependent conditions where estrogen reduction is not desired
  • Concurrent tamoxifen/AI therapy (without oncologist approval)
  • Pregnancy/lactation

Best Stacking Partners

Calcium D-Glucarate (Phase II estrogen clearance)SulforaphaneNACMilk Thistle

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →